Histocell Competitors and Similar CompaniesClear all

Histocell's competitors and similar companies include Kanghong Pharmaceutical, Neofluidics, Intra-Cellular Therapies and Lutonix.

	Histocell Histocell is a biopharmaceutical company focused on the development, manufacturing, and commercialization of medical devices, active ingredients, and cell therapy drugs for regenerative medicine.	Kanghong Pharmaceutical Kanghong Pharmaceutical (成都康弘药业集团股份有限公司) is a company that produces and sells biological products.	Neofluidics Neofluidics is a company that develops tools and technology for enhanced microfluidics.	Intra-Cellular Therapies Intra-Cellular Therapies develops drugs for the treatment of neuropsychiatric and neurologic diseases, and other disorders of the CNS.	Lutonix Lutonix DCB is a new drug-coated balloon catheter that delivers paclitaxel to the arterial wall in a single, short inflation.
Founding Date	Founding Date 2011	Founding Date 1996	Founding Date 2014	Founding Date 2002	Founding Date 2007
Type	Type Private	Type Public	Type Private	Type Public	Type Subsidiary
Tags	Tags Healthcare biotech drug development medical devices	Tags Healthcare biotech drug development medical devices	Tags Healthcare biotech drug development medical devices	Tags Healthcare biotech drug development medical devices	Tags Healthcare biotech drug development medical devices
Locations	Locations Derio, ES HQ Larrabetzu, ES	Locations Cheng Du Shi, CN HQ	Locations San Diego, US HQ Lubbock, US	Locations New York, US HQ	Locations Maple Grove, US HQ
Employees	Employees 365% decrease	Employees 4,462	Employees 3	Employees 330352% increase	Employees 10
Valuation ($)	Valuation ($) N/A	Valuation ($) 2.5 b	Valuation ($) N/A	Valuation ($) 8.1 b	Valuation ($) N/A
Financial
Revenue (est.)	Revenue (est.) N/A	Revenue (est.) ¥4.5b (FY, 2025)	Revenue (est.) N/A	Revenue (est.) $680.9m (FY, 2024)	Revenue (est.) N/A
Net income	Net income N/A	Net income ¥1.1b (FY, 2025)	Net income N/A	Net income ($74.7m) (FY, 2024)	Net income N/A
Funding
Total funding raised	Total funding raised N/A	Total funding raised N/A	Total funding raised $ 3.2m	Total funding raised $ 225.3m	Total funding raised $ 35m